Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors
- PMID: 32497105
- PMCID: PMC7271989
- DOI: 10.1371/journal.pone.0233501
Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors
Abstract
Introduction: People living with HIV (PLWH) had a higher prevalence and incidence rate of bone fracture compared to general population. Although several studies have explored this phenomenon, the prevalence and incidence rate of fracture were varied.
Objective: The aim of the study is to determine and analyze the pooled prevalence, incidence rate of fracture and fracture risk factors among people living with HIV (PLWH).
Methods: PubMed, Cochrane Library, CINAHL with full Text, and Medline databases for studies published up to August 2019 were searched. Studies reporting the prevalence or incidence of fracture among PLWH were included. Study quality was assessed using the Joanna Briggs Institute (JBI) appraisal tool. A meta-analysis with random-effects model was performed to determine pooled estimates of prevalence and incidence rates of fracture. A meta-regression was performed to determine the source of heterogeneity.
Results: The pooled estimated prevalence of fracture among PLWH was 6.6% (95% CI: 3.8-11.1) with pooled odds ratio of 1.9 (95%CI: 1.1-3.2) compared to the general population. The pooled estimates of fracture incidence were 11.3 per 1000 person-years (95% CI: 7.9-14.5) with incidence rate ratio (IRR) of 1.5 (95% CI: 1.3-1.8) compared to the general population. Risk factors for fracture incidence were older age (aHR 1.4, 95% CI: 1.3-1.6), smoking (aHR 1.3, 95% CI: 1.1-1.5), HIV/HCV co-infection (aHR 1.6, 95% CI: 1.3-1.9), and osteoporosis (aHR 3.3, 95% CI: 2.2-5.1).
Conclusions: Our finding highlights a higher risk of fracture among PLWH compared to the general population. Osteoporosis, smoking and HIV/HCV coinfection as the significant modifiable risk factors should be prioritized by the HIV health providers when care for PLWH.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis.Arch Osteoporos. 2021 Feb 27;16(1):47. doi: 10.1007/s11657-021-00903-y. Arch Osteoporos. 2021. PMID: 33638754 Review.
-
The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.PLoS One. 2014 Jul 17;9(7):e101493. doi: 10.1371/journal.pone.0101493. eCollection 2014. PLoS One. 2014. PMID: 25033046 Free PMC article.
-
Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study.AIDS. 2012 Jan 28;26(3):285-93. doi: 10.1097/QAD.0b013e32834ed8a7. AIDS. 2012. PMID: 22095195
-
Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients.J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):205-10. doi: 10.1097/QAI.0b013e31821ecf4c. J Acquir Immune Defic Syndr. 2011. PMID: 21522014
-
HIV and fracture: Risk, assessment and intervention.HIV Med. 2024 May;25(5):511-528. doi: 10.1111/hiv.13596. Epub 2023 Dec 12. HIV Med. 2024. PMID: 38087902 Review.
Cited by
-
Bone Loss and Fractures in Post-Menopausal Women Living with HIV: A Narrative Review.Pathogens. 2024 Sep 19;13(9):811. doi: 10.3390/pathogens13090811. Pathogens. 2024. PMID: 39339002 Free PMC article. Review.
-
Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility.J Pers Med. 2024 Jul 26;14(8):791. doi: 10.3390/jpm14080791. J Pers Med. 2024. PMID: 39201983 Free PMC article. Review.
-
Effect of Oral Bisphosphonates on Vertebral Fractures in Males Living with HIV: A Seven Year Study.J Clin Med. 2024 Oct 30;13(21):6526. doi: 10.3390/jcm13216526. J Clin Med. 2024. PMID: 39518665 Free PMC article.
-
Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda.Lancet Glob Health. 2022 May;10(5):e694-e704. doi: 10.1016/S2214-109X(22)00080-8. Lancet Glob Health. 2022. PMID: 35427526 Free PMC article.
-
Bone Disease in HIV: Need for Early Diagnosis and Prevention.Life (Basel). 2024 Apr 17;14(4):522. doi: 10.3390/life14040522. Life (Basel). 2024. PMID: 38672792 Free PMC article. Review.
References
-
- Compston J. HIV infection and bone disease. Journal of Internal Medicine. 2016;280(4):350–8. - PubMed
-
- Hansen AB, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. Aids. 2012;26(3):285–93. - PubMed
-
- Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, et al. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management. AIDS Patient Care STDS. 2015;29(4):169–80. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical